LXRX
Lexicon Pharmaceuticals, Inc.
$1.71
Earnings Summary
Revenue | $0.7Mn |
Net Profits | $-48.24Mn |
Net Profit Margins | -6872.36% |
Highlights
Lexicon Pharmaceuticals, Inc.’s revenue jumped 2407.14% since last year same period to $0.7Mn in the Q4 2023. On a quarterly growth basis, Lexicon Pharmaceuticals, Inc. has generated 333.33% jump in its revenue since last 3-months.
Lexicon Pharmaceuticals, Inc.’s net profit fell -57.1% since last year same period to $-48.24Mn in the Q4 2023. On a quarterly growth basis, Lexicon Pharmaceuticals, Inc. has generated 4.51% jump in its net profits since last 3-months.
Lexicon Pharmaceuticals, Inc.’s net profit margin jumped 93.73% since last year same period to -6872.36% in the Q4 2023. On a quarterly growth basis, Lexicon Pharmaceuticals, Inc. has generated 77.96% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Lexicon Pharmaceuticals, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.2 |
EPS Estimate Current Year | -0.2 |
Highlights
Lexicon Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.2 - a 9.09% jump from last quarter’s estimates.
Lexicon Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -0.2.
Key Ratios
Key ratios of the Lexicon Pharmaceuticals, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.2 |
Highlights
Lexicon Pharmaceuticals, Inc.’s earning per share (EPS) fell -25% since last year same period to -0.2 in the Q4 2023. This indicates that the Lexicon Pharmaceuticals, Inc. has generated -25% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-03-25 | -0.22 | -0.2 | 9.09% |
2023-08-04 | -0.17 | -0.22 | -29.41% |
2023-05-04 | -0.18 | -0.17 | 5.56% |
2023-11-08 | -0.21 | -0.21 | 0% |
₹0 US Stocks a/c Opening Fee